On Apr. 23, 2020, Emergent BioSolutions announced an agreement whereby Emergent will deploy its contract development and manufacturing…
On Apr. 23, 2020, CHF Solutions announced that it had shipped the first commercial orders of its next…
On Apr. 23, 2020, the Mayo Clinic, Minnesota Department of Health and University of Minnesota announced a breakthrough…
On Apr. 23, 2020, Western New York healthcare and medical research leaders joined forces in an effort to…
On Apr. 22, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Immunomedics’ Trodelvy (sacituzumab…
On Apr. 22, 2020, researchers at Massachusetts Institute of Technology (MIT); the Ragon Institute of MGH, and Harvard…
On Apr. 22, 2020, Cocrystal Pharma announced it has expanded its previously announced license agreement with Kansas State…
On Apr. 21, 2020, the Janssen Pharmaceutical Companies of Johnson & Johnson announced U.S. Food and Drug Administration…
On Apr. 21, 2020, a study posted on medRxiv found no evidence that use of hydroxychloroquine, either with…
On Apr. 21, 2020, BioSig Technologies announced that subsidiary ViralClear Pharmaceuticals, had submitted an application for Vicromax(tm) (merimepodib,…
On Apr. 21, 2020, Rutgers University announced it has launched the nation’s largest prospective study of health care…
On Apr. 21, 2020, Todos Medical announced that Gnomegen has received Emergency Use Authorization from the FDA for…
On Apr. 21, 2020, to fight the novel coronavirus pandemic, Cleveland Clinic and SAS announced they had created…
On Apr. 21, 2020, Pharnext and the University Hospital Institute Mediterranee Infection in France, announced a new joint…
On Apr. 20, 2020, Novartis has reached an agreement with the FDA to proceed with a Phase III…
On Apr. 20, 2020, RedHill Biopharma announced an agreement with the National Institute of Allergy and Infectious Diseases…
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…
On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…
On Apr. 17, 2020, after promising COVID-19 treatments in Germany, France, Italy, Spain and the U.S,, ExThera Medical’s…
On Apr. 17, 2020, Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled phase 3 clinical…
On Apr. 17, 2020, Celdara Medical announced that it had entered into a Cooperative Research and Development Agreement…
On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…
On Apr. 17, 2020, Seagen announced the FDA granted approval to TUKYSA (tucatinib) tablets in combination with trastuzumab…
On Apr. 17, 2020, the University of Washington Medicine announced that a new clinical blood test will be…
On Apr. 16, 2020, BioSig Technologies announced that its subsidiary ViralClear Pharmaceuticals, had updated its clinical development program…
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
On Apr. 16, 2020, OpGen announced that a study on the feasibility and potential of antibiotic susceptibility testing…